Biomedical NLP models improve healthcare delivery by assisting with diagnostics, treatment recommendations, and extracting medical information from vast amounts of biomedical literature and patient records. They help identify patterns and insights that can lead to better patient outcomes and more informed medical research, enhancing clinical decision-making and healthcare delivery overall.
The accuracy of biomedical NLP models is affected by the variability in drug nomenclature and context-specific medical terminologies. Existing benchmarks like MedQA and MedMCQA often fail to account for these variations, leading to inconsistencies and errors in model outputs. The fragility of language models to variations in drug names poses a critical issue in biomedical NLP, highlighting the need for specialized benchmarks like RABBITS to assess model performance accurately.
The RABBITS dataset is designed to evaluate the performance of language models in the healthcare domain by assessing their robustness and accuracy in handling diverse and context-specific medical terminologies, particularly focusing on variations in drug names, such as brand and generic drug names12. This evaluation aims to simulate real-world variability in drug nomenclature and provide a more accurate assessment of language models' capabilities in handling medical terminology1.